Chen Shirui, Li Zhen, Hu Xia, Zhang Hui, Chen Weiwei, Xu Qiongqiong, Tang Lili, Ge Huiyao, Zhen Qi, Yong Liang, Yu Yafen, Cao Lu, Zhang Ruixue, Hao Yong, Shi Jihai, Sun Liangdan
Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, #69 Meishan Road, Hefei, 230022, Anhui, China.
Department of Dermatology, Chengdu Second People's Hospital, Chengdu, 610021, China.
Clin Rheumatol. 2022 Nov;41(11):3461-3470. doi: 10.1007/s10067-022-06292-y. Epub 2022 Jul 19.
Familial cold autoinflammatory syndrome (FCAS) is the mildest subtype of cryopyrin-associated periodic syndrome (CAPS) and is a rare inherited systemic autoinflammatory disease (SAID). CAPS is the consequence of a rare group of genetic disorders that are mostly reported in European and American populations, but scarcely reported in Chinese populations. NLRP3, NLRP12, PLCG2, and NLRC4 are known pathogenic genes associated with FCAS, and the aim of this study was to identify pathogenic mutations in two intact pedigrees of Chinese FCAS. We performed Sanger sequencing of genomic DNA samples from 25 affected and 32 unaffected members of the two intact pedigrees and analyzed the pathogenic mutations for their conservativeness using multiple sequence alignment tools. In addition, we reviewed previously reported pathogenic genes of FCAS and their pathogenicity classification and summarized the characteristics of different genotypes and phenotypes of FCAS. This study reported two intact FCAS pedigrees with different genotypes and phenotypes, the heterozygous mutation (p.V72M) in NLRP3 in pedigree 1 and the heterozygous mutation (p.R754H) in NLRP12 in pedigree 2. There are no reports targeting p.V72M in NLRP3 in FCAS1, and there are relatively few relevant phenotypic data on the clinical manifestations identified in previous pedigrees. Multiple sequence comparisons of NLRP3 indicate that the p.V72M mutation is highly conserved during evolution. Our study has enriched the understanding of the pathogenesis of FCAS, a rare disease especially in Asian populations. KEY POINTS: •The NLRP3 (p.V72M) variant was first discovered in the Chinese pedigree of FCAS1 •NLRP12 (p.R754H) variants are not conserved in multiple sequence alignments, but they are still co-segregated and expressed in the big Chinese diseased pedigree.
家族性冷性自身炎症综合征(FCAS)是冷吡啉相关周期性综合征(CAPS)中最轻微的亚型,是一种罕见的遗传性全身性自身炎症性疾病(SAID)。CAPS是一组罕见的遗传疾病的结果,大多在欧美人群中报道,但在中国人群中鲜有报道。NLRP3、NLRP12、PLCG2和NLRC4是已知与FCAS相关的致病基因,本研究的目的是在中国FCAS的两个完整家系中鉴定致病突变。我们对两个完整家系中25名患者和32名未患病成员的基因组DNA样本进行了桑格测序,并使用多序列比对工具分析了致病突变的保守性。此外,我们回顾了先前报道的FCAS致病基因及其致病性分类,并总结了FCAS不同基因型和表型的特征。本研究报道了两个具有不同基因型和表型的完整FCAS家系,家系1中NLRP3的杂合突变(p.V72M)和家系2中NLRP12的杂合突变(p.R754H)。在FCAS1中,尚无针对NLRP3中p.V72M的报道,且先前家系中鉴定出的临床表现相关的表型数据相对较少。NLRP3的多序列比较表明,p.V72M突变在进化过程中高度保守。我们的研究丰富了对FCAS发病机制的理解,FCAS是一种罕见疾病,尤其是在亚洲人群中。要点:•NLRP3(p.V72M)变异首次在中国FCAS1家系中发现•NLRP12(p.R754H)变异在多序列比对中不保守,但仍在大型中国患病家系中共同分离和表达。